Journal of Traditional Chinese Medicine ›› 2024, Vol. 44 ›› Issue (6): 1091-1103.DOI: 10.19852/j.cnki.jtcm.20240926.001
• Meta-Analyses • Previous Articles Next Articles
WANG Bingyu1,2, JIN Fangfang1, GAO Jiawei1, YANG Liuxin1, ZHANG Yali3, YUAN Xingxing1,2(), ZHANG Yang4()
Received:
2023-09-11
Accepted:
2023-12-08
Online:
2024-12-15
Published:
2024-09-26
Contact:
Prof. ZHANG Yang, Department of Gastroenterology, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China. zhangyanghljucm@126.com Telephone: +86-45187588511Supported by:
WANG Bingyu, JIN Fangfang, GAO Jiawei, YANG Liuxin, ZHANG Yali, YUAN Xingxing, ZHANG Yang. Acupuncture reduces sedative and anaesthetic consumption and improves pain tolerance in patients undergoing colonoscopy: a Meta-analysis[J]. Journal of Traditional Chinese Medicine, 2024, 44(6): 1091-1103.
Study ID | Country | Sample size (M/F) | Age (years) | Study group (n) | Intervention group | Control group | Outcome |
---|---|---|---|---|---|---|---|
Li CK et al 1991 | Germany | 36 (18/18) | 50/55/47 | Intervention (12) | Acupuncture before and during colonoscopy | Sham acupuncture | ③④ |
Control-1 (12) | Acupoint: LI4, PC6, ST36, SP4, bilaterally | None | |||||
Control-2 (12) | |||||||
Wang HH et al 1997 | Taiwan, China | 59 (34/25) | 49/50 | Intervention (30) | Electroacupuncture before and during colonoscopy | Meperidine 50 mg | ②④⑥ |
Control (29) | Acupoint: ST36, ST37, unilaterally | ||||||
Aurical acupoint: EP11, bilaterally | |||||||
Zhang ZH 2000 | China | 68 (NR) | NR | Intervention (34) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ⑤ |
Control (34) | Acupoint: ST36, unilaterally + Atropine 0.15mg | ||||||
Zhao DS et al 2001 | China | 267 (148/119) | 42.7/43.1 | Intervention (136) | Acupressure during colonoscopy | None | ④ |
Control (131) | Acupoint: LI4, unilaterally | ||||||
Chen Y et al 2002 | China | 82 (50/32) | NR | Intervention (41) | Acupuncture before and during colonoscopy | None | ②④ |
Control (41) | Acupoint: LI4, PC6, LI10, ST36, unilaterally | ||||||
Fanti L et al 2003 | Italy | 30 (10/20) | 63/60/55 | Intervention (10) | Electroacupuncture before and during colonoscopy | Sham acupuncture + Midazolam/ | ①②④ |
Control-1 (10) | Acupoint: LI4, ST36, SP6, SP9, EP11, bilaterally | Midazolam | |||||
Control-2(10) | Midazolam | ||||||
Mi XL et al 2003 | China | 100 (60/40) | NR | Intervention (50) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ② |
Control (50) | Acupoint: ST36, unilaterally | ||||||
Atropine 0.25 mg. | |||||||
Qin FR et al 2003 | China | 80 (62/18) | NR | Intervention (40) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ⑤ |
Control (40) | Acupoint: ST36, unilaterally | ||||||
Atropine 0.15 mg. | |||||||
Yang AL et al 2003 | China | 80 (62/18) | NR | Intervention (40) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ⑤ |
Control (40) | Acupoint: ST36, unilaterally | ||||||
Atropine 0.15 mg | |||||||
Yang AL et al 2005 | China | 200 (142/58) | 37.4/38.7 | Intervention (100) | Acupressure before and during colonoscopy | None | ②④ |
Control (100) | Acupoint: PC6, ST36, unilaterally | ||||||
Li Q et al 2005 | China | 200 (78/122) | 38.6/39.1 | Intervention (100) | Auricular acupressure | None | ②⑥ |
Control (100) | |||||||
Du YJ et al 2006 | China | 185 (99/86) | 42.7/43.2 | Intervention (93) | Acupuncture before colonoscopy | None | ④ |
Control (92) | Acupoint: LI4, bilaterally | ||||||
Ni YF et al 2007 | China | 80 (40/40) | 43/45 | Intervention (40) | Electroacupuncture before and during colonoscopy | None | ④⑥ |
Control (40) | Acupoint: LI4, bilaterally; ST36, ST37, SP9, SP6, unilaterally | ||||||
Ni YF et al 2009 | China | 60 (29/31) | 43.25/45.31 | Intervention (30) | Electroacupuncture before and during colonoscopy | Midazolam 0.02 mg/kg | ①③④⑥ |
Control (30) | Acupoint: LI4, bilaterally; ST36, ST37, SP9, SP6, unilaterally | ||||||
Midazolam 0.02 mg/kg | |||||||
Study ID | Country | Sample size (M/F) | Age (years) | Study group (n) | Intervention group | Control group | Outcome |
Lin JL et al 2010 | China | 100 (43/57) | NR | Intervention (50) | Pharmacoacupuncture before colonoscopy | Tramadol 100 mg Anisodamine 0.5 mg | ②④ |
Control (50) | Acupoint: SP6, bilaterally, | ||||||
Tramadol 100 mg | |||||||
Anisodamine 0.5 mg | |||||||
Xu JH et al 2010 | China | 93 (65/28) | 45.21/46.18 | Intervention (34) | Auricular acupressure | None | ③ |
Control (59) | |||||||
Lin JX et al 2013 | China | 220 (149/71) | 37.2/38.4 | Intervention (110) | Acupressure before and during colonoscopy | None | ②④ |
Control (110) | Acupoint: LI4, ST36, unilaterally | ||||||
Ng S et al 2013 | Hong Kong, China | 128 (64/64) | NR | Intervention (64) | Acupuncture before and during colonoscopy | Sham acupuncture | ①③④ |
Control (64) | Acupoint: LI4, PC6, ST36, unilaterally | Propofol | |||||
Propofol | |||||||
Wu CL et al 2016 | China | 199 (100/99) | 51.8/52.1 | Intervention (98) | Auricular acupressure | None | ③④ |
Control (101) | |||||||
Zhao J et al 2016 | China | 72 (39/33) | 51/52 | Intervention (36) | Acupuncture before and during colonoscopy | None | ②④ |
Control (36) | Acupoint: ST36, unilaterally | ||||||
Guo HY et al 2017 | China | 140 (86/54) | 42.6/43.1 | Intervention (70) | Pharmacoacupuncture before colonoscopy | Anisodamine 10 mg | ④ |
Control (70) | Acupoint: ST36, bilaterally | ||||||
Anisodamine 10 mg | |||||||
Acupressure during colonoscopy | |||||||
Acupoint: PC6 | |||||||
Liang H | China | 1310 (687/623) | 43.4/40.3/42.6 | Intervention (455) | Auricular acupressure | ③④ | |
201747 | Control-1 (407) | Propofol | |||||
Control-2 (448) | |||||||
Luo YY et al 2018 | China | 120 (69/51) | 43.8/44.0 | Intervention (60) | Acupuncture before colonoscopy | Propofol 1-2 mg/kg | ①②⑤ |
Control (60) | Acupoint: LI4, PC6, ST36 | ||||||
Luo YY et al 2019 | China | 80 (42/38) | 48.5/48.8 | Intervention (40) | Acupuncture before colonoscopy | Propofol 1-2 mg/kg | ①④⑤⑥ |
Control (40) | Acupoint: LI4, PC6, LI10, Ashi, ST36, unilaterally | ||||||
Propofol 1-2 mg/kg | |||||||
Eberl S et al 2020 | Netherlands | 153 (60/93) | 62/65/63 | Intervention (51) | Electroacupuncture before and during colonoscopy | Sham acupuncture Placebo-acupuncture Propofol/Alfentanil | ①③④ |
Control-1 (51) | Acupoint: ST36, PC6, LI4, unilaterally | ||||||
Control-2 (51) | Propofol/Alfentanil | ||||||
Zheng XY et al 2020 | China | 160 (87/73) | 62.38/62.34 | Intervention (80) | Acupuncture before and during colonoscopy | None | ②④ |
Control (80) | Acupoint: LI10, ST36, PC6, bilaterally, LI4, unilaterally | ||||||
Study ID | Country | Sample size (M/F) | Age (years) | Study group (n) | Intervention group | Control group | Outcome |
Chen Y et al 2021 | China | 32 (21/11) | 71.3/71.6 | Intervention (16) | Transcutaneous electrical acupuncture point stimulation before colonoscopy | Sham transcutaneous electrical acupuncture point stimulation | ① |
Control (16) | Acupoint: PC6, bilaterally | fentanyl 50 μg | |||||
fentanyl 50 μg | Propofol 1.5-2.5 mg/kg | ||||||
Propofol 1.5-2.5 mg/kg | |||||||
Joan Gan CY et al 2021 | Malaysia | 37 (20/17) | 65/61 | Intervention (19) | Transcutaneous electrical acupuncture point stimulation during colonoscopy | Sham transcutaneous electrical acupuncture point stimulation | ③④ |
Control (18) | Acupoint: ST36 bilaterally | ||||||
He T et al 2022 | China | 181 (86/95) | 49.34/49.73 | Intervention (91) | Acupuncture before and during colonoscopy | Nabufine 0.025 mg/kg | ①③④⑥ |
Control (90) | Acupoint: wrist-ankle, unilaterally | Propofol 0.5 mg/kg | |||||
Nabufine 0.025 mg/kg | |||||||
Propofol 0.5 mg/kg | |||||||
Li Y et al 2023 | China | 78 (51/27) | 67.01/67.63 | Intervention (39) | Acupuncture before and during colonoscopy | Propofol 1 mg/kg | ②⑤⑥ |
Control (39) | Acupoint: ST36, PC6, LI4, bilaterally | ||||||
Propofol 1 mg/kg | |||||||
Fentanyl 5 μg/kg |
Table 1 Characteristics of the included studies
Study ID | Country | Sample size (M/F) | Age (years) | Study group (n) | Intervention group | Control group | Outcome |
---|---|---|---|---|---|---|---|
Li CK et al 1991 | Germany | 36 (18/18) | 50/55/47 | Intervention (12) | Acupuncture before and during colonoscopy | Sham acupuncture | ③④ |
Control-1 (12) | Acupoint: LI4, PC6, ST36, SP4, bilaterally | None | |||||
Control-2 (12) | |||||||
Wang HH et al 1997 | Taiwan, China | 59 (34/25) | 49/50 | Intervention (30) | Electroacupuncture before and during colonoscopy | Meperidine 50 mg | ②④⑥ |
Control (29) | Acupoint: ST36, ST37, unilaterally | ||||||
Aurical acupoint: EP11, bilaterally | |||||||
Zhang ZH 2000 | China | 68 (NR) | NR | Intervention (34) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ⑤ |
Control (34) | Acupoint: ST36, unilaterally + Atropine 0.15mg | ||||||
Zhao DS et al 2001 | China | 267 (148/119) | 42.7/43.1 | Intervention (136) | Acupressure during colonoscopy | None | ④ |
Control (131) | Acupoint: LI4, unilaterally | ||||||
Chen Y et al 2002 | China | 82 (50/32) | NR | Intervention (41) | Acupuncture before and during colonoscopy | None | ②④ |
Control (41) | Acupoint: LI4, PC6, LI10, ST36, unilaterally | ||||||
Fanti L et al 2003 | Italy | 30 (10/20) | 63/60/55 | Intervention (10) | Electroacupuncture before and during colonoscopy | Sham acupuncture + Midazolam/ | ①②④ |
Control-1 (10) | Acupoint: LI4, ST36, SP6, SP9, EP11, bilaterally | Midazolam | |||||
Control-2(10) | Midazolam | ||||||
Mi XL et al 2003 | China | 100 (60/40) | NR | Intervention (50) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ② |
Control (50) | Acupoint: ST36, unilaterally | ||||||
Atropine 0.25 mg. | |||||||
Qin FR et al 2003 | China | 80 (62/18) | NR | Intervention (40) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ⑤ |
Control (40) | Acupoint: ST36, unilaterally | ||||||
Atropine 0.15 mg. | |||||||
Yang AL et al 2003 | China | 80 (62/18) | NR | Intervention (40) | Pharmacoacupuncture before colonoscopy | Atropine 0.5 mg | ⑤ |
Control (40) | Acupoint: ST36, unilaterally | ||||||
Atropine 0.15 mg | |||||||
Yang AL et al 2005 | China | 200 (142/58) | 37.4/38.7 | Intervention (100) | Acupressure before and during colonoscopy | None | ②④ |
Control (100) | Acupoint: PC6, ST36, unilaterally | ||||||
Li Q et al 2005 | China | 200 (78/122) | 38.6/39.1 | Intervention (100) | Auricular acupressure | None | ②⑥ |
Control (100) | |||||||
Du YJ et al 2006 | China | 185 (99/86) | 42.7/43.2 | Intervention (93) | Acupuncture before colonoscopy | None | ④ |
Control (92) | Acupoint: LI4, bilaterally | ||||||
Ni YF et al 2007 | China | 80 (40/40) | 43/45 | Intervention (40) | Electroacupuncture before and during colonoscopy | None | ④⑥ |
Control (40) | Acupoint: LI4, bilaterally; ST36, ST37, SP9, SP6, unilaterally | ||||||
Ni YF et al 2009 | China | 60 (29/31) | 43.25/45.31 | Intervention (30) | Electroacupuncture before and during colonoscopy | Midazolam 0.02 mg/kg | ①③④⑥ |
Control (30) | Acupoint: LI4, bilaterally; ST36, ST37, SP9, SP6, unilaterally | ||||||
Midazolam 0.02 mg/kg | |||||||
Study ID | Country | Sample size (M/F) | Age (years) | Study group (n) | Intervention group | Control group | Outcome |
Lin JL et al 2010 | China | 100 (43/57) | NR | Intervention (50) | Pharmacoacupuncture before colonoscopy | Tramadol 100 mg Anisodamine 0.5 mg | ②④ |
Control (50) | Acupoint: SP6, bilaterally, | ||||||
Tramadol 100 mg | |||||||
Anisodamine 0.5 mg | |||||||
Xu JH et al 2010 | China | 93 (65/28) | 45.21/46.18 | Intervention (34) | Auricular acupressure | None | ③ |
Control (59) | |||||||
Lin JX et al 2013 | China | 220 (149/71) | 37.2/38.4 | Intervention (110) | Acupressure before and during colonoscopy | None | ②④ |
Control (110) | Acupoint: LI4, ST36, unilaterally | ||||||
Ng S et al 2013 | Hong Kong, China | 128 (64/64) | NR | Intervention (64) | Acupuncture before and during colonoscopy | Sham acupuncture | ①③④ |
Control (64) | Acupoint: LI4, PC6, ST36, unilaterally | Propofol | |||||
Propofol | |||||||
Wu CL et al 2016 | China | 199 (100/99) | 51.8/52.1 | Intervention (98) | Auricular acupressure | None | ③④ |
Control (101) | |||||||
Zhao J et al 2016 | China | 72 (39/33) | 51/52 | Intervention (36) | Acupuncture before and during colonoscopy | None | ②④ |
Control (36) | Acupoint: ST36, unilaterally | ||||||
Guo HY et al 2017 | China | 140 (86/54) | 42.6/43.1 | Intervention (70) | Pharmacoacupuncture before colonoscopy | Anisodamine 10 mg | ④ |
Control (70) | Acupoint: ST36, bilaterally | ||||||
Anisodamine 10 mg | |||||||
Acupressure during colonoscopy | |||||||
Acupoint: PC6 | |||||||
Liang H | China | 1310 (687/623) | 43.4/40.3/42.6 | Intervention (455) | Auricular acupressure | ③④ | |
201747 | Control-1 (407) | Propofol | |||||
Control-2 (448) | |||||||
Luo YY et al 2018 | China | 120 (69/51) | 43.8/44.0 | Intervention (60) | Acupuncture before colonoscopy | Propofol 1-2 mg/kg | ①②⑤ |
Control (60) | Acupoint: LI4, PC6, ST36 | ||||||
Luo YY et al 2019 | China | 80 (42/38) | 48.5/48.8 | Intervention (40) | Acupuncture before colonoscopy | Propofol 1-2 mg/kg | ①④⑤⑥ |
Control (40) | Acupoint: LI4, PC6, LI10, Ashi, ST36, unilaterally | ||||||
Propofol 1-2 mg/kg | |||||||
Eberl S et al 2020 | Netherlands | 153 (60/93) | 62/65/63 | Intervention (51) | Electroacupuncture before and during colonoscopy | Sham acupuncture Placebo-acupuncture Propofol/Alfentanil | ①③④ |
Control-1 (51) | Acupoint: ST36, PC6, LI4, unilaterally | ||||||
Control-2 (51) | Propofol/Alfentanil | ||||||
Zheng XY et al 2020 | China | 160 (87/73) | 62.38/62.34 | Intervention (80) | Acupuncture before and during colonoscopy | None | ②④ |
Control (80) | Acupoint: LI10, ST36, PC6, bilaterally, LI4, unilaterally | ||||||
Study ID | Country | Sample size (M/F) | Age (years) | Study group (n) | Intervention group | Control group | Outcome |
Chen Y et al 2021 | China | 32 (21/11) | 71.3/71.6 | Intervention (16) | Transcutaneous electrical acupuncture point stimulation before colonoscopy | Sham transcutaneous electrical acupuncture point stimulation | ① |
Control (16) | Acupoint: PC6, bilaterally | fentanyl 50 μg | |||||
fentanyl 50 μg | Propofol 1.5-2.5 mg/kg | ||||||
Propofol 1.5-2.5 mg/kg | |||||||
Joan Gan CY et al 2021 | Malaysia | 37 (20/17) | 65/61 | Intervention (19) | Transcutaneous electrical acupuncture point stimulation during colonoscopy | Sham transcutaneous electrical acupuncture point stimulation | ③④ |
Control (18) | Acupoint: ST36 bilaterally | ||||||
He T et al 2022 | China | 181 (86/95) | 49.34/49.73 | Intervention (91) | Acupuncture before and during colonoscopy | Nabufine 0.025 mg/kg | ①③④⑥ |
Control (90) | Acupoint: wrist-ankle, unilaterally | Propofol 0.5 mg/kg | |||||
Nabufine 0.025 mg/kg | |||||||
Propofol 0.5 mg/kg | |||||||
Li Y et al 2023 | China | 78 (51/27) | 67.01/67.63 | Intervention (39) | Acupuncture before and during colonoscopy | Propofol 1 mg/kg | ②⑤⑥ |
Control (39) | Acupoint: ST36, PC6, LI4, bilaterally | ||||||
Propofol 1 mg/kg | |||||||
Fentanyl 5 μg/kg |
Figure 3 Forest plot of acupuncture on consumption of sedatives and anesthetics, pain tolerance and VAS score A: consumption of sedatives and anesthetics; B: pain tolerance; C: VAS score. CI: confidence interval; VAS: visual analogue scale.
Figure 4 Forest plot of acupuncture on mean time consumption of examination, satisfaction and adverse reaction A: mean time consumption of examination; B: satisfaction; C: adverse reaction. CI: confidence interval.
Subgroup | Number of studies | Number of participants | Random effect model | Heterogeneity | |||
---|---|---|---|---|---|---|---|
OR/SMD/MD (95% CI) | P value | I 2 value (%) | P value | ||||
Consumption of sedatives and anesthetics | |||||||
Manual acupuncture | 669 | -1.37 (-1.93, 0.82) | <0.001 | 90 | <0.001 | ||
Electroacupuncture | 243 | -0.45 (-0.98, 0.07) | 0.09 | 77 | 0.002 | ||
Transcutaneous electrical acupuncture point stimulation | 32 | 0.83 (0.10, 1.55) | 0.03 | / | / | ||
Pain tolerance | |||||||
Manual acupuncture | 672 | 4.65 (1.86, 11.64) | 0.001 | 83 | <0.001 | ||
Electroacupuncture | 89 | 5.51 (0.56, 54.51) | 0.14 | 71 | 0.03 | ||
Pharmacoacupuncture | 280 | 9.33 (4.25, 20.49) | <0.001 | 16 | 0.30 | ||
Auricular acupressure | 200 | 85.09 (28.14, 257.28) | <0.001 | / | / | ||
Acupressure | 420 | 9.28 (5.78, 14.91) | <0.001 | 11 | 0.29 | ||
VAS score | |||||||
Manual acupuncture | 345 | -0.71 (-1.35, 0.07) | 0.03 | 95 | <0.001 | ||
Electroacupuncture | 213 | -0.79 (-1.63, 0.06) | 0.07 | 97 | <0.001 | ||
Auricular acupressure | 1195 | -2.15 (-3.60, 0.69) | 0.004 | 97 | <0.001 | ||
Transcutaneous electrical acupuncture point stimulation | 37 | -1.40 (-4.36, 1.56) | 0.35 | / | / | ||
Mean time consumption of examination | |||||||
Manual acupuncture | 1124 | -3.20 (-5.48, 0.92) | 0.006 | 98 | <0.001 | ||
Electroacupuncture | 402 | -0.10 (-2.62, 2.43) | 0.94 | 75 | 0.0005 | ||
Pharmacoacupuncture | 240 | -3.77 (-4.47, 3.08) | <0.001 | 0 | 0.94 | ||
Auricular acupressure | 1509 | -1.51 (-4.10, 1.07) | 0.25 | 97 | <0.001 | ||
Acupressure | 487 | -3.39 (-3.89, 2.89) | <0.001 | 0 | 0.59 | ||
Transcutaneous electrical acupuncture point stimulation | 37 | 1.00 (-0.30, 2.30) | 0.13 | / | / | ||
Satisfaction | |||||||
Manual acupuncture | 181 | 0.26 (-0.03, 0.55) | 0.08 | / | / | ||
Electroacupuncture | 323 | -0.21 (-0.77, 0.35) | 0.47 | 85 | <0.001 | ||
Pharmacoacupuncture | 140 | 0.84 (0.49, 1.18) | <0.001 | / | / | ||
Auricular acupressure | 199 | 0.16 (-0.12, 0.44) | 0.27 | / | / | ||
Adverse reactions | |||||||
Manual acupuncture | 339 | 0.17 (0.10, 0.30) | <0.001 | 0 | 0.43 | ||
Electroacupuncture | 199 | 0.15 (0.04, 0.52) | 0.003 | 0 | 0.86 | ||
Auricular acupressure | 200 | 0.20 (0.01, 4.14) | 0.29 | / | / |
Table 2 Subgroup analyses
Subgroup | Number of studies | Number of participants | Random effect model | Heterogeneity | |||
---|---|---|---|---|---|---|---|
OR/SMD/MD (95% CI) | P value | I 2 value (%) | P value | ||||
Consumption of sedatives and anesthetics | |||||||
Manual acupuncture | 669 | -1.37 (-1.93, 0.82) | <0.001 | 90 | <0.001 | ||
Electroacupuncture | 243 | -0.45 (-0.98, 0.07) | 0.09 | 77 | 0.002 | ||
Transcutaneous electrical acupuncture point stimulation | 32 | 0.83 (0.10, 1.55) | 0.03 | / | / | ||
Pain tolerance | |||||||
Manual acupuncture | 672 | 4.65 (1.86, 11.64) | 0.001 | 83 | <0.001 | ||
Electroacupuncture | 89 | 5.51 (0.56, 54.51) | 0.14 | 71 | 0.03 | ||
Pharmacoacupuncture | 280 | 9.33 (4.25, 20.49) | <0.001 | 16 | 0.30 | ||
Auricular acupressure | 200 | 85.09 (28.14, 257.28) | <0.001 | / | / | ||
Acupressure | 420 | 9.28 (5.78, 14.91) | <0.001 | 11 | 0.29 | ||
VAS score | |||||||
Manual acupuncture | 345 | -0.71 (-1.35, 0.07) | 0.03 | 95 | <0.001 | ||
Electroacupuncture | 213 | -0.79 (-1.63, 0.06) | 0.07 | 97 | <0.001 | ||
Auricular acupressure | 1195 | -2.15 (-3.60, 0.69) | 0.004 | 97 | <0.001 | ||
Transcutaneous electrical acupuncture point stimulation | 37 | -1.40 (-4.36, 1.56) | 0.35 | / | / | ||
Mean time consumption of examination | |||||||
Manual acupuncture | 1124 | -3.20 (-5.48, 0.92) | 0.006 | 98 | <0.001 | ||
Electroacupuncture | 402 | -0.10 (-2.62, 2.43) | 0.94 | 75 | 0.0005 | ||
Pharmacoacupuncture | 240 | -3.77 (-4.47, 3.08) | <0.001 | 0 | 0.94 | ||
Auricular acupressure | 1509 | -1.51 (-4.10, 1.07) | 0.25 | 97 | <0.001 | ||
Acupressure | 487 | -3.39 (-3.89, 2.89) | <0.001 | 0 | 0.59 | ||
Transcutaneous electrical acupuncture point stimulation | 37 | 1.00 (-0.30, 2.30) | 0.13 | / | / | ||
Satisfaction | |||||||
Manual acupuncture | 181 | 0.26 (-0.03, 0.55) | 0.08 | / | / | ||
Electroacupuncture | 323 | -0.21 (-0.77, 0.35) | 0.47 | 85 | <0.001 | ||
Pharmacoacupuncture | 140 | 0.84 (0.49, 1.18) | <0.001 | / | / | ||
Auricular acupressure | 199 | 0.16 (-0.12, 0.44) | 0.27 | / | / | ||
Adverse reactions | |||||||
Manual acupuncture | 339 | 0.17 (0.10, 0.30) | <0.001 | 0 | 0.43 | ||
Electroacupuncture | 199 | 0.15 (0.04, 0.52) | 0.003 | 0 | 0.86 | ||
Auricular acupressure | 200 | 0.20 (0.01, 4.14) | 0.29 | / | / |
1. | Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges. World J Gastroenterol 2019; 25: 190-204. |
2. | Nass KJ, van der Schaar PJ, van der Vlugt M, et al. Continuous monitoring of colonoscopy performance in the Netherlands: first results of a nationwide registry. Endoscopy 2022; 54: 488-95. |
3. |
Trevisani L, Zelante A, Sartori S. Colonoscopy, pain and fears: is it an indissoluble trinomial? World J Gastrointest Endosc 2014; 6: 227-33.
DOI PMID |
4. | Chung YW, Han DS, Yoo KS, Park CK. Patient factors predictive of pain and difficulty during sedation-free colonoscopy: a prospective study in Korea. Dig Liver Dis 2007; 39: 872-6. |
5. | Dafnis G, Granath F, Pahlman L, Ekbom A, Blomqvist P. Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis 2005; 37: 113-8. |
6. |
Bynum SA, Davis JL, Green BL, Katz RV. Unwillingness to participate in colorectal cancer screening: examining fears, attitudes, and medical mistrust in an ethnically diverse sample of adults 50 years and older. Am J Health Promot 2012; 26: 295-300.
DOI PMID |
7. |
Green AR, Peters-Lewis A, Percac-Lima S, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 2008; 23: 834-40.
DOI PMID |
8. |
Early DS, Saifuddin T, Johnson JC, King PD, Marshall JB. Patient attitudes toward undergoing colonoscopy without sedation. Am J Gastroenterol 1999; 94: 1862-5.
DOI PMID |
9. |
Cohen LB. Sedation issues in quality colonoscopy. Gastrointest Endosc Clin N Am 2010; 20: 615-27.
DOI PMID |
10. |
Ladas SD, Satake Y, Mostafa I, Morse J. Sedation practices for gastrointestinal endoscopy in Europe, North America, Asia, Africa and Australia. Digestion 2010; 82: 74-6.
DOI PMID |
11. | Triantafillidis JK, Merikas E, Nikolakis D, Papalois AE. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol 2013; 19: 463-81. |
12. |
Karanth H, Murali S, Koteshwar R, Shetty V, Adappa K. Comparative study between propofol and dexmedetomidine for conscious sedation in patients undergoing outpatient colonoscopy. Anesth Essays Res 2018; 12: 98-102.
DOI PMID |
13. |
Rex DK, Overley C, Kinser K, et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol 2002; 97: 1159-63.
DOI PMID |
14. |
Muller S, Borowics SM, Fortis EA, et al. Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP. Gastrointest Endosc 2008; 67: 651-9.
DOI PMID |
15. | Zhu J, Li J, Yang L, Liu S. Acupuncture, from the ancient to the current. Anat Rec (Hoboken) 2021; 304: 2365-71. |
16. | Hu N, Ma L, Wang P, et al. Influence of the quickness and duration of De Qi on the analgesic effect of acupuncture in primary dysmenorrhea patients with a cold and dampness stagnation pattern. J Tradit Chin Med 2019; 39: 258-66. |
17. |
Odine Maria Rego B, Cesar B, Marcelo P, et al. Changes in sternocleidomastoid and descending portion of trapezius muscles in terms of electromyography and pressure pain threshold: women with chronic neck pain after acupuncture treatment. J Tradit Chin Med 2020; 40: 144-9.
PMID |
18. |
Gao XM, Wang CY, Ni Y, Zhang HL. Clinical effect of acupuncture along fascia, meridians, and nerves combined with ultrasound-guided paravertebral nerve block in the treatment of postherpetic neuralgia: a randomized parallel-controlled study. J Tradit Chin Med 2023; 43: 359-64.
DOI |
19. | You Y, Zhang T, Shu S, Qian X, Zhou S, Yao F. Wrist-ankle acu-puncture and Fluoxetine in the treatment of post-stroke depression: a randomized controlled clinical trial. J Tradit Chin Med 2020; 40: 455-60. |
20. | Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and Meta-analyses of studies that evaluate healthcare interventions: explanation and elabo-ration. BMJ 2009; 339: b2700. |
21. | Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. |
22. |
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; 14: 135.
DOI PMID |
23. |
Higgins JP, Thompson SG. Quantifying heterogeneity in a Meta-analysis. Stat Med 2002; 21: 1539-58.
DOI PMID |
24. | Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in Meta-analyses. BMJ 2003; 327: 557-60. |
25. |
Egger M, Davey Smith G, Schneider M, Minder C. Bias in Meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
DOI PMID |
26. | Li CK, Nauck M, Loser C, Folsch UR, Creutzfeldt W. Acupuncture to alleviate pain during colonoscopy. Dtsch Med Wochenschr 1991; 116: 367-70. |
27. | Wang HH, Chang YH, Liu DM, Ho YJ. A clinical study on physiological response in electroacupuncture analgesia and meperidine analgesia for colonoscopy. Am J Chin Med 1997; 25: 13-20. |
28. | Zhang ZH. Observation on analgesic effect of acupoint injection for fiber colonoscopy. Zhong Hua Hu Li Za Zhi 2000; 35: 619. |
29. | Zhao DS, Du YJ, Kang YP. Application of finger-pressing at Hegu point in colonoscopy. Zhong Guo Zhen Jiu 2001; 21: 477-9. |
30. | Chen Y, Luo HY, Liu SH, Song JM, He KZ. Study on the acupuncture analgesia during electronic colonoscopy. Hu Li Xue Za Zhi 2002; 17: 86-8. |
31. |
Fanti L, Gemma M, Passaretti S, et al. Electroacupuncture analgesia for colonoscopy. a prospective, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 312-6.
PMID |
32. | Mi XL, Wu JG, Lu QF, Liu HP. Clinical research in analgesic effect of atropin point-injection by colonoscopy. Tianjin Hu Li 2003; 11: 66-7. |
33. | Qin FR, Yin ZF. Analgesic effect of atropine injection at the Zusanli point on patient during colonoscopy. Anhui Zhong Yi Lin Chuang Za Zhi 2003; 15: 492. |
34. | Yang AL, Tian HD. Observation on 40 cases of point injection of Zusanli for colonoscopy. Zhong Guo Lin Chuang Yi Sheng 2003; 31: 46. |
35. | Yang AL, Li J, Tian DH. Clinical observation on analgesic effect of pressing point with the finger used in patients undergoing colonoscopy. Hu Li Xue Za Zhi 2005; 20: 30-1. |
36. | Li Q, Zhang Y. Application of auricular acupoint paste and pressing therapy in fibrocolonoscopy. Zhong Guo Gang Chang Bing Za Zhi 2005; 25: 37-8. |
37. | Du YJ, Sun GJ. Influence of needling point Hegu (LI4) on colonoscopy. J Acupunct Tuina Sci 2006; 4: 183-5. |
38. | Ni YF, Lian QQ, Jiang PW, Xu YQ. Application of acupuncture analgesia in colonoscopy. Zhong Guo Zhen Jiu 2007; 27: 766-8. |
39. | Ni YF, Li J, Wang BF, et al. Effects of electroacupuncture on bispectral index and plasma beta-endorphin in patients undergoing colonoscopy. Zhen Ci Yan Jiu 2009; 34: 339-43. |
40. | Lin JL, Wang PB, He GL. Observation on analgesic effect of tramadol acupoint injection combined with atropine on colonoscopy. Zhong Guo Shi Yong Yi Yao 2010; 5: 188-9. |
41. | Xu JH, Jin HY, Wu KL, Ding YJ. Observation on the effect of auricular acupressure on the pain tolerance duiring colonoscopy. Shanxi Zhong Yi 2010; 31: 1053-4. |
42. | Lin JX, Chen Y, Liu XW. Clinical observation and nursing effect of acupressure analgesia for colonoscopy. Taishan Yi Xue Yuan Xue Bao 2013; 34: 380-1. |
43. | Ng S, Leung WWA, Chan SK, Wong CY, Lee JF. Electroacupuncture analgesia for colonoscopy: a prospective, randomized, sham-controlled study. Gastrointestinal Endoscopy 2013; 77: Ab176. |
44. | Wu CL, Wang JY, Yao W, Zhou S. Clinical study of auricular acupressure for single person colonoscopy. Zhong Yi Yao Dao Bao 2016; 22: 101-3. |
45. | Zhao J, Pan J. Application of acupuncture at Zusanli on colonoscopy. Guang Ming Zhong Yi 2016; 31: 685-6. |
46. | Guo HY, Long R, Zhang SZ, Yang J, Yang ZF, Yang JG. Clinical observation of 654-2 acupoint injection at Zusanli combined with shiatsu at Neiguan acupoint for colonoscopy analgesia. Zhong Guo Zhong Yi Yao Xin Xi Za Zhi 2017; 24: 30-3. |
47. | Liang H. Application of ear-pressing therapy in electro-coionoscopy. Zhong Guo Gang Chang Bing Za Zhi 2017; 37: 54-6. |
48. | Luo YY, Tian L, Liu MN, Liu JL. The effect of acupuncture combined with propofol on pain relief, stress response, and hemodynamics in patients undergoing colonoscopy. Zhong Guo Shi Yan Zhen Duan Xue 2018; 22: 1804-6. |
49. | Luo YY, Liu MN, Jia HX, Jin XF, Tian L, LIU JL. Feasibility of combination of acupuncture and propofol for painless colonoscopy. Xian Dai Sheng Wu Yi Xue Jin Zhan 2019; 19: 924-7. |
50. |
Eberl S, Monteiro de Olivera N, Bourne D, et al. Effect of electroacupuncture on sedation requirements during colonoscopy: a prospective placebo-controlled randomised trial. Acupunct Med 2020; 38: 131-9.
DOI PMID |
51. | Zheng XY, Ye JL, Huang SM. Study on effects of acupuncture on electronic enteroscopy. Sheng Wu Yi Xue Gong Cheng Xue Jin Zhan 2020; 41: 163-5. |
52. | Zhu GQ. Effect of Acupuncture analgesia combined with propofol on pain degree and stress response in patients undergoing enteroscopy. Xin Zhong Yi 2020; 52: 122-4. |
53. |
Chen Y, Gong Y, Huai X, et al. Effects of transcutaneous electrical acupuncture point stimulation on peripheral capillary oxygen saturation in elderly patients undergoing colonoscopy with sedation: a prospective randomized controlled trial. Acupunct Med 2021; 39: 292-8.
DOI PMID |
54. |
Joan Gan CY, Chan KK, Tan JH, Tan Chor Lip H, Louis Ling LL, Mohd Azman ZA. Smartphone-controlled patch electro-acupuncture versus conventional pain relief during colonoscopy: a randomized controlled trial. ANZ J Surg 2021; 91: E375-81.
DOI PMID |
55. |
He T, Liu C, Lu ZX, et al. Effect of wrist-ankle acupuncture on propofol dosage during painless colonoscopy: a randomized controlled prospective study. World J Clin Cases 2022; 10: 3764-72.
DOI PMID |
56. | Li Y, Hao W, Liu FF, et al. Randomized controlled study of acupuncture combined with alfentanil hydrochloride for painless colonoscopy in elderly patients. Zhong Guo Zhong Yi Yao Xue Kan 2023; 41: 255-8. |
57. | Vase L, Baram S, Takakura N, et al. Can acupuncture treatment be double-blinded? An evaluation of double-blind acupuncture treatment of postoperative pain. PLoS One 2015; 10: e0119612. |
58. | Manfredi L. Endorobots for colonoscopy: design challenges and available technologies. Front Robot AI 2021; 8: 705454. |
59. |
Hassan C, Spadaccini M, Iannone A, et al. Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and Meta-analysis. Gastrointest Endosc 2021; 93: 77-85+e6.
DOI PMID |
60. |
Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2019; 156: 254-72+e11.
DOI PMID |
61. | Krigel A, Chen L, Wright JD, Lebwohl B. Substantial increase in anesthesia assistance for outpatient colonoscopy and associated cost nationwide. Clin Gastroenterol Hepatol 2019; 17: 2489-96. |
62. |
Inadomi JM, Gunnarsson CL, Rizzo JA, Fang H. Projected increased growth rate of anesthesia professional-delivered sedation for colonoscopy and EGD in the United States: 2009 to 2015. Gastrointest Endosc 2010; 72: 580-6.
DOI PMID |
63. |
Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks associated with anesthesia services during colonoscopy. Gastroenterology 2016; 150: 888-94.
DOI PMID |
64. |
Rex DK, Vargo JJ. Anesthetist-directed sedation for colonoscopy: a safe haven or siren's song? Gastroenterology 2016; 150: 801-3.
DOI PMID |
65. | Ren JJ, Tian HC, Wang YF, et al. Effectiveness and safety of moxibustion for poststroke insomnia: a systematic review and Meta-analysis. World J Tradit Chin Med 2022; 8: 199-209. |
66. | Zhang XW, Gu YJ, Wu HG, et al. Systematic review and meta-analysis of acupuncture for pain caused by liver cancer. World J Tradit Chin Med 2022; 8: 402-12. |
67. | Zhao JM, Li L, Chen L, et al. Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome. World J Gastroenterol 2017; 23: 2928-39. |
68. |
Chu D, Cheng P, Xiong H, Zhang J, Liu S, Hou X. Electroacupuncture at ST-36 relieves visceral hypersensitivity and decreases 5-HT(3) receptor level in the colon in chronic visceral hypersensitivity rats. Int J Colorectal Dis 2011; 26: 569-74.
DOI PMID |
69. |
Wang J, Xia Q, Zhu F, et al. Effects of acupuncture on adverse events in colonoscopy: a systematic review and Meta-analysis of randomized controlled trials. Pain Ther 2022; 11: 1095-112.
DOI PMID |
70. | Ahmad A, Marshall S, Bassett P, Thiruvilangam K, Dhillon A, Saunders BP. Evaluation of bowel preparation regimens for colonoscopy including a novel low volume regimen (Plenvu): CLEANSE study. BMJ Open Gastroenterol 2023; 10: e001070. |
71. |
Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998; 19: 159-66.
DOI PMID |
72. | Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869. |
73. | Wei C, Xu Y, Deng X, Gao S, Wan X, Chen J. Assessment of reporting completeness in acupuncture studies on patients with functional constipation using the STRICTA guidelines. Complement Ther Med 2022; 70: 102849. |
[1] | GAN Chang, TAO Qingwen, YI Haoying, BIAN Yuting, WANG Jianming. Network Meta-analysis of the clinical efficacy and safety of kidney-tonifying and bone-strengthening therapies for the treatment of rheumatoid arthritis with kidney deficiency type [J]. Journal of Traditional Chinese Medicine, 2024, 44(6): 1067-1081. |
[2] | XU Jian, LIU Yuntao, LUO Zhihao, ZHAO Zhen, WANG Dawei, LIU Qing. Chinese patent medicine for atherosclerosis: a systematic review and Meta-analysis of randomized controlled trials [J]. Journal of Traditional Chinese Medicine, 2024, 44(6): 1082-1090. |
[3] | WU Ruixin, FANG Qingliang, GUAN Sisi, WEI Xianglong, SHAN Mengjun, MAO Zhujun, GONG Yabin, XU Ling, ZHOU Di, DONG Changsheng. A pilot study of precision treatment for patients with lung cancer pain by Longteng Tongluo recipe (龙藤通络方) using serum genomics [J]. Journal of Traditional Chinese Medicine, 2024, 44(5): 1006-1016. |
[4] | XU Yingshan, WU Chunxiao, YU Wei, GUO Hongji, LU Liming, XU Nenggui, TANG Chunzhi. Systematic review and Meta-analysis of brain plasticity associated with electroacupuncture in experimental ischemic stroke [J]. Journal of Traditional Chinese Medicine, 2024, 44(5): 859-870. |
[5] | DENG Yasheng, HAN Siyin, XI Lanhua, HUANG Hui, LIANG Tianwei, ZHENG Yiqing, FAN Yanping, LIN Jiang. Traditional Chinese Medicine in the treatment of recurrent respiratory tract infections in children: an overview of systematic reviews and Meta-analyses [J]. Journal of Traditional Chinese Medicine, 2024, 44(5): 871-884. |
[6] | YU Siyun, ZHANG Shiwen, XIA Yu, LIU Xiaoqing, LIU Yajie, FU Jinrong. Network-based pharmacology and experimental validation to explore the mechanism of action of the Jiawei Pentongling formula (加味盆痛灵方) for the treatment of endometriosis-related pain [J]. Journal of Traditional Chinese Medicine, 2024, 44(5): 991-999. |
[7] | CHEN Dandan, JIN Qianhong, SHEN Yuanjuan, WANG Qing, DAI Zhengxiang. Scraping therapy for knee osteoarthritis: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2024, 44(4): 633-641. |
[8] | ZHU Ruifang, ZHANG Jun, LYU Yaru, CHEN Yulu, HAN Shifan, WANG Hongwei. Efficacy of substances containing 3 types of active ingredients-saponins, flavones, and alkaloids in regulation of cytokines in autoimmune diseases a systematic review and Meta-analysis based on animal studies [J]. Journal of Traditional Chinese Medicine, 2024, 44(3): 417-426. |
[9] | MO Xiaoqiang, CHEN Yating, YIN Qian, CHEN Haibo, BAN Qiang, LI Jun, CHEN Su, YAO Jinguang. Transient receptor potential vanilloid 1 involved in the analgesic effects of total flavonoids extracted from Longxuejie (Resina Dracaenae Cochinchinensis) [J]. Journal of Traditional Chinese Medicine, 2024, 44(3): 437-447. |
[10] | WANG Shaosong, SUN Jingqing, FENG Qingyin, LI Bin, WANG Xin, YUAN Fan, CUI Yingxue. Effectivenss of electroacupuncture for skeletal muscle pain in Parkinson's disease: a Clinical randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2024, 44(2): 388-395. |
[11] | PING Jing, HAO Hongzheng, WU Zhenqi, ZOU Meijuan, LI Zuojing, CHENG Gang. Long-term efficacy and safety of Huangqi (Radix Astragali Mongolici)-based Traditional Chinese Medicine in diabetic peripheral neuropathy: a Meta-analysis of randomized controlled trials [J]. Journal of Traditional Chinese Medicine, 2024, 44(2): 229-242. |
[12] | ZHOU Mingwang, DONG Zhuanli, WEI Changhao, FENG Lufang, WANG Xiaoping, LIU Haiping, JI Xing, YANG Kehu, LI Shenghua. Efficacy and safety of extracorporeal shock wave therapy combined with sodium hyaluronate in treatment of knee osteoarthritis: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2024, 44(2): 243-250. |
[13] | QIN Xiaoyu, WANG Chunai, XUE Jianjun, ZHANG Jie, LU Xiaoting, DING Shengshuang, GE Long, WANG Minzhen. Efficacy of electroacupuncture on myocardial protection and postoperative rehabilitation in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2024, 44(1): 1-15. |
[14] | LIU Tingting, LIU Tongou, LIU Mingfu. Effectiveness and safety of acupuncture in treatment of pregnancy-related symptoms: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2024, 44(1): 16-26. |
[15] | YANG Yi, YE Huijun, ZHENG Huiling, JIN Lihua. Clinical observation on 90 cases of primary dysmenorrhea treated by buccal acupuncture therapy: a randomized controlled study [J]. Journal of Traditional Chinese Medicine, 2024, 44(1): 172-181. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
Sponsored by China Association of Chinese Medicine
& China Academy of Chinese Medical Sciences
16 Nanxiaojie, Dongzhimen Nei, Beijing, China. 100700 Email: jtcmen@126.com
Copyright 2020 Journal of Traditional Chinese Medicine. All rights reserved.